E Fund Management »

BioMarin Pharmaceutical shares owned by E Fund Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 236 56.49

More positions owned by E Fund Management

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
PDD Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
Apple (AAPL)
Yum China Holdings (YUMC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Newmont Mining Corporation (NEM)
Broadcom (AVGO)
H World Group Sponsored Ads (HTHT)
Meta Platforms Cl A (META)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for E Fund Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Viking Global Investors
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Capital Research Global Investors
Millennium Management

View all funds holding BioMarin Pharmaceutical